Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:53
05/26/23
05/26
09:53
05/26/23
09:53
CVS

CVS Health

$67.88 /

+0.21 (+0.31%)

, DOC

Physicians Realty Trust

$13.50 /

+0.005 (+0.04%)

, MSGE

MSG Entertainment

$34.95 /

-0.74 (-2.07%)

, ITGR

Integer

$79.79 /

-0.38 (-0.47%)

, PARA

Paramount

$14.75 /

+0.665 (+4.72%)

, NEWR

New Relic

$80.80 /

+2.58 (+3.30%)

, HLNE

Hamilton Lane

$65.93 /

+0.07 (+0.11%)

, CSR

Centerspace

$57.51 /

-0.19 (-0.33%)

, SNOW

Snowflake

$148.02 /

-0.095 (-0.06%)

, EQR

Equity Residential

$58.38 /

-1.085 (-1.82%)

, MDB

MongoDB

$279.00 /

-6.235 (-2.19%)

, ANNX

Annexon

$2.14 /

+0.055 (+2.64%)

, LIN

Linde

$358.14 /

+1.57 (+0.44%)

, UNH

UnitedHealth

$481.48 /

+3.82 (+0.80%)

The most talked about and…

ShowHide Related Items >><<
UNH UnitedHealth
$481.48 /

+3.82 (+0.80%)

SNOW Snowflake
$148.02 /

-0.095 (-0.06%)

PARA Paramount
$14.75 /

+0.665 (+4.72%)

NEWR New Relic
$80.80 /

+2.58 (+3.30%)

MSGE MSG Entertainment
$34.95 /

-0.74 (-2.07%)

MDB MongoDB
$279.00 /

-6.235 (-2.19%)

LIN Linde
$358.14 /

+1.57 (+0.44%)

ITGR Integer
$79.79 /

-0.38 (-0.47%)

HLNE Hamilton Lane
$65.93 /

+0.07 (+0.11%)

EQR Equity Residential
$58.38 /

-1.085 (-1.82%)

DOC Physicians Realty Trust
$13.50 /

+0.005 (+0.04%)

CVS CVS Health
$67.88 /

+0.21 (+0.31%)

CSR Centerspace
$57.51 /

-0.19 (-0.33%)

ANNX Annexon
$2.14 /

+0.055 (+2.64%)

CVS CVS Health
$67.88 /

+0.21 (+0.31%)

05/25/23 Piper Sandler
CVS Health initiated with an Overweight at Piper Sandler
05/25/23 Deutsche Bank
CVS could use buybacks to offset earnings shortfalls, says Deutsche Bank
05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
DOC Physicians Realty Trust
$13.50 /

+0.005 (+0.04%)

05/26/23 JMP Securities
Physicians Realty Trust initiated with an Outperform at JMP Securities
05/05/23 Barclays
Physicians Realty Trust price target lowered to $17 from $18 at Barclays
04/19/23 Wells Fargo
Physicians Realty Trust initiated with an Underweight at Wells Fargo
03/27/23 Compass Point
Physicians Realty Trust price target lowered to $19 from $21 at Compass Point
MSGE MSG Entertainment
$34.95 /

-0.74 (-2.07%)

05/26/23 Morgan Stanley
MSG Entertainment initiated with an Equal Weight at Morgan Stanley
05/26/23 Goldman Sachs
MSG Entertainment initiated with a Neutral at Goldman Sachs
05/17/23 Guggenheim
MSG Entertainment initiated with Buy on NYC assets at Guggenheim
05/17/23 Guggenheim
MSG Entertainment initiated with a Buy at Guggenheim
ITGR Integer
$79.79 /

-0.38 (-0.47%)

05/26/23 Wells Fargo
Integer initiated with an Equal Weight at Wells Fargo
05/11/23 Citi
Integer initiated with a Neutral at Citi
04/28/23 KeyBanc
Integer price target raised to $96 from $86 at KeyBanc
03/30/23 BofA
BofA starts Integer at Neutral, says margin expansion key to upside
PARA Paramount
$14.75 /

+0.665 (+4.72%)

05/26/23 Loop Capital
Loop Capital upgrades Paramount to Hold as controlling shareholder raises funds
05/26/23 Loop Capital
Paramount upgraded to Hold from Sell at Loop Capital
05/24/23 Deutsche Bank
Paramount price target lowered to $25 from $28 at Deutsche Bank
NEWR New Relic
$80.80 /

+2.58 (+3.30%)

05/26/23 DA Davidson
DA Davidson positive on New Relic ability to accelerate growth
05/26/23 RBC Capital
RBC upgrades New Relic on accelerating growth visibility
05/26/23 RBC Capital
New Relic upgraded to Outperform from Sector Perform at RBC Capital
05/24/23 Truist
New Relic price target raised to $77 from $65 at Truist
HLNE Hamilton Lane
$65.93 /

+0.07 (+0.11%)

05/26/23 Oppenheimer
Hamilton Lane upgraded to Outperform on valuation at Oppenheimer
05/26/23 Wells Fargo
Hamilton Lane price target lowered to $71 from $73 at Wells Fargo
05/26/23 Oppenheimer
Hamilton Lane upgraded to Outperform from Perform at Oppenheimer
03/15/23 JPMorgan
Hamilton Lane upgraded to Overweight from Neutral at JPMorgan
CSR Centerspace
$57.51 /

-0.19 (-0.33%)

05/26/23 Raymond James
Raymond James upgrades Centerspace to Market Perform on leasing demand
05/26/23 Raymond James
Centerspace upgraded to Market Perform from Underperform at Raymond James
05/02/23 Colliers
Centerspace upgraded to Buy from Neutral at Colliers
04/05/23 Piper Sandler
Centerspace price target lowered to $62 from $66 at Piper Sandler
SNOW Snowflake
$148.02 /

-0.095 (-0.06%)

05/26/23 Wolfe Research
Wolfe downgrades Snowflake amid growing competition from Microsoft
05/26/23 Citi
Snowflake price target lowered to $189 from $202 at Citi
05/26/23 Bernstein
Snowflake price target lowered to $148 from $157 at Bernstein
05/25/23 Wolfe Research
Snowflake downgraded to Peer Perform from Outperform at Wolfe Research
EQR Equity Residential
$58.38 /

-1.085 (-1.82%)

05/26/23 Raymond James
Equity Residential downgraded to Underperform at Raymond James
05/19/23 Mizuho
Equity Residential price target lowered to $68 from $72 at Mizuho
05/01/23 Piper Sandler
Equity Residential price target raised to $63 from $59 at Piper Sandler
03/29/23 Wells Fargo
Equity Residential initiated with an Equal Weight at Wells Fargo
MDB MongoDB
$279.00 /

-6.235 (-2.19%)

05/26/23 Guggenheim
MongoDB downgraded to Sell at Guggenheim on growth and valuation concerns
05/25/23 Guggenheim
MongoDB downgraded to Sell from Neutral at Guggenheim
05/15/23 Barclays
MongoDB price target raised to $280 from $257 at Barclays
ANNX Annexon
$2.14 /

+0.055 (+2.64%)

05/26/23 BofA
Annexon downgraded to Neutral at BofA after ARCHER results
05/26/23 BofA
Annexon downgraded to Neutral from Buy at BofA
05/25/23 BTIG
Annexon price target lowered to $7 from $15 at BTIG
05/25/23 JPMorgan
Annexon downgraded to Neutral from Overweight at JPMorgan
LIN Linde
$358.14 /

+1.57 (+0.44%)

05/26/23 Oddo BHF
Oddo double downgrades Linde on energy transition costs
05/25/23 Oddo BHF
Linde downgraded to Underperform from Outperform at Oddo BHF
05/12/23 Berenberg
Linde price target raised to $415 from $375 at Berenberg
05/08/23 HSBC
Linde price target raised to $416 from $380 at HSBC
UNH UnitedHealth
$481.48 /

+3.82 (+0.80%)

05/25/23 Piper Sandler
UnitedHealth initiated with an Overweight at Piper Sandler
04/20/23 Cantor Fitzgerald
UnitedHealth initiated with an Overweight at Cantor Fitzgerald
04/17/23 Deutsche Bank
UnitedHealth price target raised to $627 from $617 at Deutsche Bank
04/17/23 TD Cowen
UnitedHealth price target lowered to $562 from $596 at TD Cowen
UNH UnitedHealth
$481.48 /

+3.82 (+0.80%)

SNOW Snowflake
$148.02 /

-0.095 (-0.06%)

PARA Paramount
$14.75 /

+0.665 (+4.72%)

NEWR New Relic
$80.80 /

+2.58 (+3.30%)

MSGE MSG Entertainment
$34.95 /

-0.74 (-2.07%)

MDB MongoDB
$279.00 /

-6.235 (-2.19%)

LIN Linde
$358.14 /

+1.57 (+0.44%)

ITGR Integer
$79.79 /

-0.38 (-0.47%)

HLNE Hamilton Lane
$65.93 /

+0.07 (+0.11%)

EQR Equity Residential
$58.38 /

-1.085 (-1.82%)

DOC Physicians Realty Trust
$13.50 /

+0.005 (+0.04%)

CVS CVS Health
$67.88 /

+0.21 (+0.31%)

CSR Centerspace
$57.51 /

-0.19 (-0.33%)

ANNX Annexon
$2.14 /

+0.055 (+2.64%)

  • 07
    Mar
UNH UnitedHealth
$481.48 /

+3.82 (+0.80%)

SNOW Snowflake
$148.02 /

-0.095 (-0.06%)

PARA Paramount
$14.75 /

+0.665 (+4.72%)

NEWR New Relic
$80.80 /

+2.58 (+3.30%)

MSGE MSG Entertainment
$34.95 /

-0.74 (-2.07%)

LIN Linde
$358.14 /

+1.57 (+0.44%)

EQR Equity Residential
$58.38 /

-1.085 (-1.82%)

CVS CVS Health
$67.88 /

+0.21 (+0.31%)

UNH UnitedHealth
$481.48 /

+3.82 (+0.80%)

SNOW Snowflake
$148.02 /

-0.095 (-0.06%)

PARA Paramount
$14.75 /

+0.665 (+4.72%)

NEWR New Relic
$80.80 /

+2.58 (+3.30%)

MSGE MSG Entertainment
$34.95 /

-0.74 (-2.07%)

MDB MongoDB
$279.00 /

-6.235 (-2.19%)

LIN Linde
$358.14 /

+1.57 (+0.44%)

ITGR Integer
$79.79 /

-0.38 (-0.47%)

EQR Equity Residential
$58.38 /

-1.085 (-1.82%)

CVS CVS Health
$67.88 /

+0.21 (+0.31%)

UNH UnitedHealth
$481.48 /

+3.82 (+0.80%)

SNOW Snowflake
$148.02 /

-0.095 (-0.06%)

PARA Paramount
$14.75 /

+0.665 (+4.72%)

NEWR New Relic
$80.80 /

+2.58 (+3.30%)

MDB MongoDB
$279.00 /

-6.235 (-2.19%)

CVS CVS Health
$67.88 /

+0.21 (+0.31%)

Thursday
Initiation
CVS Health initiated with an Overweight at Piper Sandler » 16:08
05/25/23
05/25
16:08
05/25/23
16:08
CVS

CVS Health

$67.75 /

-1.07 (-1.55%)

, SGFY

Signify Health

$30.50 /

+ (+0.00%)

, OSH

Oak Street Health

$38.99 /

+ (+0.00%)

Piper Sandler analyst…

Piper Sandler analyst Jessica Tassan initiated coverage of CVS Health with an Overweight rating and $85 price target. CVS is "a market leader" across its healthcare financing, PBM, and retail drug store businesses and its $18B of strategic M&A earlier this year "adds value-based care delivery to the mix," the analyst tells investors. The firm feels confident in the subsequent integration efforts of the Signify (SGFY) and Oak Street (OSH) businesses under the CVS umbrella, the analyst added.

ShowHide Related Items >><<
SGFY Signify Health
$30.50 /

+ (+0.00%)

OSH Oak Street Health
$38.99 /

+ (+0.00%)

CVS CVS Health
$67.75 /

-1.07 (-1.55%)

CVS CVS Health
$67.75 /

-1.07 (-1.55%)

05/25/23 Deutsche Bank
CVS could use buybacks to offset earnings shortfalls, says Deutsche Bank
05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
05/04/23 Truist
CVS Health price target lowered to $109 from $115 at Truist
SGFY Signify Health
$30.50 /

+ (+0.00%)

03/31/23 BofA
CVS Health price target lowered to $104 from $111 at BofA
11/02/22 B. Riley
B. Riley downgrades Semler Scientific on risk from Signify buyout
09/20/22 Piper Sandler
Change Healthcare downgraded to Neutral from Overweight at Piper Sandler
OSH Oak Street Health
$38.99 /

+ (+0.00%)

05/02/23 UBS
CVS Health price target lowered to $94 from $102 at UBS
04/03/23 JPMorgan
Final Medicare Advantage rates positive for managed care, says JPMorgan
SGFY Signify Health
$30.50 /

+ (+0.00%)

OSH Oak Street Health
$38.99 /

+ (+0.00%)

CVS CVS Health
$67.75 /

-1.07 (-1.55%)

  • 17
    Aug
OSH Oak Street Health
$38.99 /

+ (+0.00%)

CVS CVS Health
$67.75 /

-1.07 (-1.55%)

SGFY Signify Health
$30.50 /

+ (+0.00%)

OSH Oak Street Health
$38.99 /

+ (+0.00%)

CVS CVS Health
$67.75 /

-1.07 (-1.55%)

SGFY Signify Health
$30.50 /

+ (+0.00%)

OSH Oak Street Health
$38.99 /

+ (+0.00%)

CVS CVS Health
$67.75 /

-1.07 (-1.55%)

Hot Stocks
CVS Health sees 2024 operating income hit of $800M-$1B due to 'star ratings' » 13:21
05/25/23
05/25
13:21
05/25/23
13:21
CVS

CVS Health

$67.42 /

-1.4 (-2.03%)

In a regulatory filing,…

In a regulatory filing, CVS Health stated: "On April 4, 2022, the U.S. Centers for Medicare & Medicaid Services, or 'CMS,' issued its final notice detailing final 2023 Medicare Advantage payment rates. Final 2023 Medicare Advantage rates resulted in an expected average increase in revenue for the Medicare Advantage industry of 5.00%, excluding the CMS estimate of Medicare Advantage risk score trend. On February 1, 2023, CMS issued an advance notice detailing proposed 2024 Medicare Advantage payment rates. The 2024 Medicare Advantage rates, if finalized as proposed, will result in an expected average decrease in revenue for the Medicare Advantage industry of 2.27%, excluding the CMS estimate of Medicare Advantage risk score trend. CMS intends to publish the final 2024 rate announcement no later than April 3, 2023. The ACA ties a portion of each Medicare Advantage plan's reimbursement to the plan's 'star ratings.' Plans must have a star rating of four or higher out of five to qualify for bonus payments. CMS released the company's 2023 star ratings in October 2022. The company's 2023 star ratings will be used to determine which of the company's Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2024. Based on the company's membership at December 31, 2022, 21% of the company's Medicare Advantage members were in plans with 2023 star ratings of at least 4.0 stars, compared to 87% of the company's Medicare Advantage members being in plans with 2022 star ratings of at least 4.0 stars based on the company's membership at December 31, 2021. The estimated impact from the decline in the number of Medicare Advantage members in plans with star ratings of at least 4.0 stars, net of mitigating actions, is a reduction of the 2024 operating income of the Health Care Benefits segment of approximately $800M to $1.0B."

ShowHide Related Items >><<
CVS CVS Health
$67.42 /

-1.4 (-2.03%)

CVS CVS Health
$67.42 /

-1.4 (-2.03%)

05/25/23 Deutsche Bank
CVS could use buybacks to offset earnings shortfalls, says Deutsche Bank
05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
05/04/23 Truist
CVS Health price target lowered to $109 from $115 at Truist
CVS CVS Health
$67.42 /

-1.4 (-2.03%)

CVS CVS Health
$67.42 /

-1.4 (-2.03%)

CVS CVS Health
$67.42 /

-1.4 (-2.03%)

CVS CVS Health
$67.42 /

-1.4 (-2.03%)

Recommendations
CVS could use buybacks to offset earnings shortfalls, says Deutsche Bank » 09:03
05/25/23
05/25
09:03
05/25/23
09:03
CVS

CVS Health

$68.82 /

-0.86 (-1.23%)

CVS Health shares are…

CVS Health shares are down 25% year-to-date, underperforming peers, as the company has invested $19B in its primary care delivery strategy, while at the same time seeing tougher COVID comparisons, increasing headwinds in 340B and concerns about pharmacy benefit managers, Deutsche Bank analyst George Hill the analyst tells investors in a research note. The firm believes CVS will use its "considerable cash flow" to offset challenges at the operating earnings line. It estimates the company could deploy over $3B per year in share repurchase to offset any operating earnings shortfalls in the near term. Deutsche also thinks CVS could announce a $1B cost reduction initiative to "attack" its $43B operating expense base as a way to drive earnings growth. The firm keeps a Hold rating on the shares with an $87 price target.

ShowHide Related Items >><<
CVS CVS Health
$68.82 /

-0.86 (-1.23%)

CVS CVS Health
$68.82 /

-0.86 (-1.23%)

05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
05/04/23 Truist
CVS Health price target lowered to $109 from $115 at Truist
05/04/23 Barclays
CVS Health price target lowered to $90 from $100 at Barclays
CVS CVS Health
$68.82 /

-0.86 (-1.23%)

CVS CVS Health
$68.82 /

-0.86 (-1.23%)

CVS CVS Health
$68.82 /

-0.86 (-1.23%)

CVS CVS Health
$68.82 /

-0.86 (-1.23%)

Wednesday
Hot Stocks
Centene names Shannon Susko chief communications officer » 07:09
05/24/23
05/24
07:09
05/24/23
07:09
CNC

Centene

$65.04 /

-0.16 (-0.25%)

Centene announced it has…

Centene announced it has named Shannon Susko as its senior VP and chief communications officer. Susko will be responsible for Centene's communications function, leading the development and execution of all internal and external communications, overseeing corporate reputation and advancing communications strategy in support of the company's business objectives.

ShowHide Related Items >><<
CNC Centene
$65.04 /

-0.16 (-0.25%)

CNC Centene
$65.04 /

-0.16 (-0.25%)

04/26/23 Stephens
Centene price target lowered to $87 from $95 at Stephens
04/26/23 Credit Suisse
Centene price target lowered to $87 from $94 at Credit Suisse
04/26/23 Barclays
Centene price target lowered to $86 from $90 at Barclays
04/20/23 Cantor Fitzgerald
Centene initiated with an Overweight at Cantor Fitzgerald
CNC Centene
$65.04 /

-0.16 (-0.25%)

CNC Centene
$65.04 /

-0.16 (-0.25%)

CNC Centene
$65.04 /

-0.16 (-0.25%)

CNC Centene
$65.04 /

-0.16 (-0.25%)

Over a week ago
Hot Stocks
Albertsons announces Tom Moriarty as general counsel » 09:08
05/19/23
05/19
09:08
05/19/23
09:08
ACI

Albertsons

$20.27 /

+0.09 (+0.45%)

, CVS

CVS Health

$69.31 /

-0.115 (-0.17%)

Albertsons (ACI)…

Albertsons (ACI) announced that Tom Moriarty will join the company as executive VP and general counsel effective June 5. Moriarty brings more than 30 years of executive leadership experience to Albertsons, including senior positions across legal, corporate strategy, policy and operations. He joins the company from CVS Health (CVS), where he spent more than 10 years serving in roles of increasing responsibility.

ShowHide Related Items >><<
CVS CVS Health
$69.31 /

-0.115 (-0.17%)

ACI Albertsons
$20.27 /

+0.09 (+0.45%)

ACI Albertsons
$20.27 /

+0.09 (+0.45%)

04/25/23 Tigress Financial
Albertsons upgraded to Buy from Neutral at Tigress Financial
04/12/23 BMO Capital
Albertsons to remain in range pending Kroger deal clarity, says BMO Capital
03/21/23 Goldman Sachs
Kimco Realty resumed with a Buy at Goldman Sachs
03/20/23 Northcoast
Kroger upgraded to Buy at Northcoast after Albertsons-fueled pullback
CVS CVS Health
$69.31 /

-0.115 (-0.17%)

05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
05/04/23 Truist
CVS Health price target lowered to $109 from $115 at Truist
05/04/23 Barclays
CVS Health price target lowered to $90 from $100 at Barclays
CVS CVS Health
$69.31 /

-0.115 (-0.17%)

ACI Albertsons
$20.27 /

+0.09 (+0.45%)

  • 23
    Feb
CVS CVS Health
$69.31 /

-0.115 (-0.17%)

ACI Albertsons
$20.27 /

+0.09 (+0.45%)

CVS CVS Health
$69.31 /

-0.115 (-0.17%)

ACI Albertsons
$20.27 /

+0.09 (+0.45%)

CVS CVS Health
$69.31 /

-0.115 (-0.17%)

ACI Albertsons
$20.27 /

+0.09 (+0.45%)

On The Fly
PBM 'regulatory noise' continues as FTC deepens inquiry into middlemen » 10:17
05/18/23
05/18
10:17
05/18/23
10:17
CVS

CVS Health

$68.43 /

-0.99 (-1.43%)

, HUM

Humana

$509.76 /

-10.53 (-2.02%)

, CI

Cigna

$256.25 /

-7.15 (-2.71%)

As part of its ongoing…

ShowHide Related Items >><<
HUM Humana
$509.76 /

-10.53 (-2.02%)

CVS CVS Health
$68.43 /

-0.99 (-1.43%)

CI Cigna
$256.25 /

-7.15 (-2.71%)

CVS CVS Health
$68.43 /

-0.99 (-1.43%)

05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
05/04/23 Truist
CVS Health price target lowered to $109 from $115 at Truist
05/04/23 Barclays
CVS Health price target lowered to $90 from $100 at Barclays
HUM Humana
$509.76 /

-10.53 (-2.02%)

05/02/23 TD Cowen
Humana price target raised to $616 from $581 at TD Cowen
04/27/23 Deutsche Bank
Humana price target raised to $568 from $562 at Deutsche Bank
04/27/23 SVB Securities
Humana price target lowered to $600 from $640 at SVB Securities
04/20/23 Cantor Fitzgerald
Humana initiated with an Overweight at Cantor Fitzgerald
CI Cigna
$256.25 /

-7.15 (-2.71%)

05/08/23 RBC Capital
Cigna price target lowered to $287 from $333 at RBC Capital
05/08/23 Deutsche Bank
Cigna price target lowered to $310 from $348 at Deutsche Bank
05/08/23 Raymond James
Cigna price target lowered to $310 from $350 at Raymond James
05/08/23 Wells Fargo
Cigna price target lowered to $284 from $355 at Wells Fargo
HUM Humana
$509.76 /

-10.53 (-2.02%)

CVS CVS Health
$68.43 /

-0.99 (-1.43%)

CI Cigna
$256.25 /

-7.15 (-2.71%)

HUM Humana
$509.76 /

-10.53 (-2.02%)

CVS CVS Health
$68.43 /

-0.99 (-1.43%)

CI Cigna
$256.25 /

-7.15 (-2.71%)

HUM Humana
$509.76 /

-10.53 (-2.02%)

CVS CVS Health
$68.43 /

-0.99 (-1.43%)

CI Cigna
$256.25 /

-7.15 (-2.71%)

HUM Humana
$509.76 /

-10.53 (-2.02%)

CVS CVS Health
$68.43 /

-0.99 (-1.43%)

CI Cigna
$256.25 /

-7.15 (-2.71%)

Options
CVS Health call volume above normal and directionally bullish » 13:45
05/16/23
05/16
13:45
05/16/23
13:45
CVS

CVS Health

$67.47 /

-1.38 (-2.00%)

Bullish option flow…

Bullish option flow detected in CVS Health with 18,756 calls trading, 1.3x expected, and implied vol increasing over 1 point to 23.92%. May-23 69 calls and May-23 65 puts are the most active options, with total volume in those strikes near 5,700 contracts. The Put/Call Ratio is 0.62. Earnings are expected on August 2nd.

ShowHide Related Items >><<
CVS CVS Health
$67.47 /

-1.38 (-2.00%)

CVS CVS Health
$67.47 /

-1.38 (-2.00%)

05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
05/04/23 Truist
CVS Health price target lowered to $109 from $115 at Truist
05/04/23 Barclays
CVS Health price target lowered to $90 from $100 at Barclays
CVS CVS Health
$67.47 /

-1.38 (-2.00%)

CVS CVS Health
$67.47 /

-1.38 (-2.00%)

CVS CVS Health
$67.47 /

-1.38 (-2.00%)

CVS CVS Health
$67.47 /

-1.38 (-2.00%)

Conference/Events
CVS Health participates in a conference call with JPMorgan » 13:45
05/11/23
05/11
13:45
05/11/23
13:45
CVS

CVS Health

$68.96 /

-0.76 (-1.09%)

Conference call with CVS…

Conference call with CVS President & CEO Lynch will be held on May 11 at 2 pm hosted by JPMorgan. Webcast Link

ShowHide Related Items >><<
CVS CVS Health
$68.96 /

-0.76 (-1.09%)

CVS CVS Health
$68.96 /

-0.76 (-1.09%)

05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
05/04/23 Truist
CVS Health price target lowered to $109 from $115 at Truist
05/04/23 Barclays
CVS Health price target lowered to $90 from $100 at Barclays
CVS CVS Health
$68.96 /

-0.76 (-1.09%)

CVS CVS Health
$68.96 /

-0.76 (-1.09%)

CVS CVS Health
$68.96 /

-0.76 (-1.09%)

CVS CVS Health
$68.96 /

-0.76 (-1.09%)

Conference/Events
CVS Health participates in a conference call with JPMorgan » 12:02
05/11/23
05/11
12:02
05/11/23
12:02
CVS

CVS Health

$69.03 /

-0.69 (-0.99%)

Conference call with CVS…

Conference call with CVS President & CEO Lynch will be held on May 11 at 2 pm hosted by JPMorgan. Webcast Link

ShowHide Related Items >><<
CVS CVS Health
$69.03 /

-0.69 (-0.99%)

CVS CVS Health
$69.03 /

-0.69 (-0.99%)

05/08/23 Wells Fargo
CVS Health price target lowered to $76 from $95 at Wells Fargo
05/08/23 Credit Suisse
CVS Health price target lowered to $96 from $125 at Credit Suisse
05/04/23 Truist
CVS Health price target lowered to $109 from $115 at Truist
05/04/23 Barclays
CVS Health price target lowered to $90 from $100 at Barclays
CVS CVS Health
$69.03 /

-0.69 (-0.99%)

CVS CVS Health
$69.03 /

-0.69 (-0.99%)

CVS CVS Health
$69.03 /

-0.69 (-0.99%)

CVS CVS Health
$69.03 /

-0.69 (-0.99%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.